We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

140 hedge funds and large institutions have $215M invested in Filana Therapeutics in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 55 increasing their positions, 31 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 31

11% more call options, than puts

Call options by funds: $65.2M | Put options by funds: $58.7M

2.81% more ownership

Funds ownership: 28.02% → 30.83% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 152 → 140 (-12)

25% less capital invested

Capital invested by funds: $287M → $215M (-$71.4M)

36% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 25

Holders
140
Holders Change
-12
Holders Change %
-7.89%
% of All Funds
2.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
55
Reduced
31
Closed
25
Calls
$65.2M
Puts
$58.7M
Net Calls
+$6.47M
Net Calls Change
+$3.48M

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$8.88M
2
Morgan Stanley
Morgan Stanley
New York
+$5.19M
3
SC
Sculptor Capital
New York
+$4.46M
4
CF
Cantor Fitzgerald
New York
+$3.38M
5
SG Americas Securities
SG Americas Securities
New York
+$2.55M

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.15M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.84M
3
Norges Bank
Norges Bank
Norway
-$1.16M
4
N
Nuveen
North Carolina
-$968K
5
Group One Trading
Group One Trading
Illinois
-$910K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
101
Tower Research Capital (TRC)
New York
$31.5K -$21.4K -1,080 -36%
CG
102
Cutler Group
California
$26K -$69.4K -3,500 -69%
IPW
103
Impact Partnership Wealth
Georgia
$25.4K +$30.2K +1,526 New
MA
104
Montag & Associates
Georgia
$25K +$9.91K +500 +50%
HI
105
Harbour Investments
Wisconsin
$17.6K +$15.9K +800 +308%
SN
106
Sittner & Nelson
Oregon
$13.3K – – –
GA
107
GoalVest Advisory
New York
$12.4K – – –
Nisa Investment Advisors
108
Nisa Investment Advisors
Missouri
$8.82K -$10.7K -540 -50%
AA
109
Ancora Advisors
Ohio
$8.32K – – –
VWM
110
Venturi Wealth Management
Texas
$8.32K – – –
AWM
111
AllSquare Wealth Management
New York
$8.29K – – –
IA
112
IFP Advisors
Florida
$7.85K +$159 +8 +2%
TWC
113
TD Waterhouse Canada
Ontario, Canada
$6.72K – – –
CAL
114
Capital Advisors Ltd
Ohio
$5K – – –
SIC
115
Salem Investment Counselors
North Carolina
$4.58K – – –
Russell Investments Group
116
Russell Investments Group
United Kingdom
$4.54K +$1.69K +85 +45%
TCM
117
Tradewinds Capital Management
Washington
$3.74K +$4.46K +225 New
SAG
118
Spotlight Asset Group
Illinois
$3.49K – – –
PP
119
PFS Partners
New Jersey
$3.33K – – –
Comerica Bank
120
Comerica Bank
Texas
$3.33K +$3.96K +200 New
BFEC
121
Benjamin F. Edwards & Company
Missouri
$3K – – –
CFD
122
Creative Financial Designs
Indiana
$2.33K – – –
LC
123
Lindbrook Capital
California
$2.18K +$1.41K +71 +118%
RMC
124
Resources Management Corp
Connecticut
$2K – – –
LFG
125
Larson Financial Group
Missouri
$1.66K – – –
3 4
5
6 7

FLNA Hedge Fund Activity: Q3 2023 in Review

140 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2023, worth a combined $215M — down 25% from $287M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of FLNA and 16 opened new positions — a net loss of 9 holders — while 31 trimmed existing stakes and 55 added.

The largest buyer was Bank of America, adding an estimated $8.88M. The largest seller was Susquehanna International Group, cutting an estimated $3.15M.

  • 140 institutional investors held Filana Therapeutics (FLNA) as of Q3 2023, down from 152 in Q2 2023.
  • Funds reported $215M of Filana Therapeutics stock for Q3 2023, down 25% quarter-over-quarter.
  • 16 funds opened new Filana Therapeutics positions in Q3 2023 and 25 closed out, a net change of -9 holders.
  • The largest Filana Therapeutics buyer in Q3 2023 was Bank of America, an estimated $8.88M added.
  • The largest Filana Therapeutics seller in Q3 2023 was Susquehanna International Group, an estimated $3.15M sold.

Based on aggregated 13F filings for Q3 2023.